NICE

Crizotinib
Sept 2016
(first line)
Alectinib
Aug 2018
(first line)
Brigatinib
Under Review
(first line)
Crizotinib
Dec 2016
(previously  treated)
Brigatinib
March 2019
(after Crizotinib)
Brigatinib
In Development
(after Cerit/Alect)
Ceritinib
Jan 2018
(first line)
Lorlatinib
May 2020
(previously treated)
Avoiding Drug Interactions
With Your TKI
ALK POSITIVE UK is a proud member of
  • Facebook
  • Twitter
  • LinkedIn Social Icon
UK Lung Cancer Coalition.jpg

ALK POSITIVE UK is a registered charity in England and Wales, registration number 1181171

©2020 by ALK Positive Lung Cancer (UK).